Quality-of-life results of an EORTC phase III randomized trial of adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases of solid tumors

被引：6
|
作者：
Soffietti, R.
Mueller, R. P.
Abacioglu, M. U.
Villa, S.
Fauchon, F.
Baumert, B.
Fariselli, L.
Tridello, G.
Kocher, M.
Bottomley, A.
机构：
[1] Univ Turin, Turin, Italy
[2] S Giovanni Battista Hosp, Turin, Italy
[3] Univ Cologne, D-50931 Cologne, Germany
[4] Marmara Univ, Istanbul, Turkey
[5] Hosp Badalona Germans Trias & Pujol, Barcelona, Spain
[6] Ctr Haute Energie, Nice, France
[7] UMC, MAASTRO GROW Res Inst, Maastricht, Netherlands
[8] Fdn Ist Neurol, Milan, Italy
[9] European Org Res Treatment Canc, Brussels, Belgium
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.9036
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9036
引用
收藏
页数：1
相关论文
共 47 条
  • [21] Quality of life after whole brain radiotherapy compared with radiosurgery of the tumor bed: results from a randomized trial
    L. Kepka
    D. Tyc-Szczepaniak
    K. Osowiecka
    A. Sprawka
    B. Trąbska-Kluch
    B. Czeremszynska
    Clinical and Translational Oncology, 2018, 20 : 150 - 159
  • [22] Stereotactic Radiosurgery versus Whole-brain Radiation Therapy for Patients with 4-15 Brain Metastases: A Phase III Randomized Controlled Trial
    Li, J.
    Ludmir, E. B.
    Wang, Y.
    Guha-Thakurta, N.
    McAleer, M. F.
    Settle, S. H., Jr.
    Yeboa, D. N.
    Ghia, A. J.
    McGovern, S. L.
    Chung, C.
    Woodhouse, K. D.
    Briere, T. M.
    Sullaway, C. M.
    Liu, D. D.
    Rao, G.
    Chang, E. L.
    Mahajan, A.
    Sulman, E. P.
    Brown, P. D.
    Wefel, J. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S21 - S22
  • [23] Hypofractionated stereotactic radiotherapy (HFSRT) versus single fraction stereotactic radiosurgery (SRS) to the resection cavity of brain metastases after surgical resection (SATURNUS): study protocol for a randomized phase III trial
    Waltenberger, Maria
    Bernhardt, Denise
    Diehl, Christian
    Gempt, Jens
    Meyer, Bernhard
    Straube, Christoph
    Wiestler, Benedikt
    Wilkens, Jan J.
    Zimmer, Claus
    Combs, Stephanie E.
    BMC CANCER, 2023, 23 (01)
  • [24] Stereotactic Radiosurgery for 1-10 Brain Metastases Avoids Whole-Brain Radiotherapy - Results of the CYBER-SPACE Randomized Phase 2 Trial
    El Shafie, R.
    Bernhardt, D.
    Schiele, A.
    Welzel, T.
    Schmitt, D.
    Thalmann, P.
    Erdem, S.
    Paul, A.
    Hoene, S. J.
    Lang, K.
    Koenig, L.
    Weykamp, F.
    Adeberg, S.
    Lentz-Hommertgen, A.
    Jaekel, C.
    Bozorgmehr, F.
    Thomas, M.
    Kieser, M.
    Debus, J.
    Rieken, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (04): : E8 - E8
  • [25] Hypofractionated stereotactic radiotherapy (HFSRT) versus single fraction stereotactic radiosurgery (SRS) to the resection cavity of brain metastases after surgical resection (SATURNUS): study protocol for a randomized phase III trial
    Maria Waltenberger
    Denise Bernhardt
    Christian Diehl
    Jens Gempt
    Bernhard Meyer
    Christoph Straube
    Benedikt Wiestler
    Jan J. Wilkens
    Claus Zimmer
    Stephanie E. Combs
    BMC Cancer, 23
  • [26] Stereotactic radiosurgery for 1-10 brain metastases to avoid whole-brain radiotherapy: Results of the CYBER-SPACE randomized phase 2 trial
    El Shafie, Rami A.
    Bernhardt, Denise
    Welzel, Thomas
    Schiele, Annabella
    Schmitt, Daniela
    Thalmann, Paul
    Erdem, Sinem
    Paul, Angela
    Hoene, Simon
    Lang, Kristin
    Koenig, Laila
    Weykamp, Fabian
    Adeberg, Sebastian
    Lentz-Hommertgen, Adriane
    Jaekel, Cornelia
    Bozorgmehr, Farastuk
    Nestle, Ursula
    Thomas, Michael
    Sander, Anja
    Kieser, Meinhard
    Debus, Juergen
    Rieken, Stefan
    NEURO-ONCOLOGY, 2024,
  • [27] Neurocognition and Quality of Life for Hypofractionated Stereotactic Radiotherapy (HFSRT) of the Resection Cavity vs. Whole-Brain Radiotherapy (WBRT) Following Brain Metastasis Resection Results of the ESTRON Randomized Phase 2 Trial
    El Shafie, R.
    Bernhardt, D.
    Welzel, T.
    Schiele, A.
    Schmitt, D.
    Thalmann, P.
    Erdem, S.
    Paul, A.
    Lang, K.
    Weykamp, F.
    Adeberg, S.
    Lentz-Hommertgen, A.
    Jaekel, C.
    Bozorgmehr, F.
    Thomas, M.
    Kieser, M.
    Debus, J.
    Rieken, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : S39 - S40
  • [28] Health-related quality of life analysis from ENTER, a randomized, controlled phase III trial of whole-brain radiotherapy with and without concurrent erlotinib in NSCLC with brain metastases
    Tang, Fei
    Zhang, Jingyi
    Xu, Zaicheng
    Zhang, Yu
    Zhang, Xiaoyue
    Peng, Yuan
    Yang, Zhenzhou
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (12)
  • [29] Quality of Life After Curative Resection for Rectal Cancer in Patients Treated With Adjuvant Chemotherapy Compared With Observation: Results of the Randomized Phase III SCRIPT Trial
    van der Valk, Maxime J. M.
    Hilling, Denise E.
    Kranenbarg, Elma Meershoek-Klein
    Peeters, Koen C. M. J.
    Kapiteijn, Ellen
    Tsonaka, Roula
    van de Velde, Cornelis J. H.
    Marang-van de Mheen, Perla J.
    DISEASES OF THE COLON & RECTUM, 2019, 62 (06) : 711 - 720
  • [30] Effects of Surgery With Salvage Stereotactic Radiosurgery Versus Surgery With Whole-Brain Radiation Therapy in Patients With One to Four Brain Metastases (JCOG0504): A Phase III, Noninferiority, Randomized Controlled Trial
    Kayama, Takamasa
    Sato, Shinya
    Sakurada, Kaori
    Mizusawa, Junki
    Nishikawa, Ryo
    Narita, Yoshitaka
    Sumi, Minako
    Miyakita, Yasuji
    Kumabe, Toshihiro
    Sonoda, Yukihiko
    Arakawa, Yoshiki
    Miyamoto, Susumu
    Beppu, Takaaki
    Sugiyama, Kazuhiko
    Nakamura, Hirohiko
    Nagane, Motoo
    Nakasu, Yoko
    Hashimoto, Naoya
    Terasaki, Mizuhiko
    Matsumura, Akira
    Ishikawa, Eiichi
    Wakabayashi, Toshihiko
    Iwadate, Yasuo
    Ohue, Shiro
    Kobayashi, Hiroyuki
    Kinoshita, Manabu
    Asano, Kenichiro
    Mukasa, Akitake
    Tanaka, Katsuyuki
    Asai, Akio
    Nakamura, Hideo
    Abe, Tatsuya
    Muragaki, Yoshihiro
    Iwasaki, Koichi
    Aoki, Tomokazu
    Watanabe, Takao
    Sasaki, Hikaru
    Izumoto, Shuichi
    Mizoguchi, Masahiro
    Matsuo, Takayuki
    Takeshima, Hideo
    Hayashi, Motohiro
    Jokura, Hidefumi
    Mizowaki, Takashi
    Shimizu, Eiji
    Shirato, Hiroki
    Tago, Masao
    Katayama, Hiroshi
    Fukuda, Haruhiko
    Shibui, Soichiro
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (33) : 3282 - +
12345